🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Eli Lilly patient assistance programs — looking for input Page 5

Eli Lilly patient assistance programs — looking for input

pam_stl Tue, Nov 11, 2025 at 2:34 PM 27 replies 1,587 viewsPage 5 of 6
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Nov 29, 2025 at 5:33 AM#21

One concrete data point for the thread. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: Nov 29, 2025 at 8:33 AM
44 19steve_okc, dave_SLC, FDA_TrackerJim and 41 others
Reply Quote Save Share Report
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
Dec 5, 2025 at 8:36 PM#22

A narrower follow-up, since the general answer is now clear:

Was that from a primary source or from a summary of one?

Last edited: Dec 6, 2025 at 1:36 AM
43 18james_edin, FranDenver, Dr.BariatricHTX and 40 others
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Dec 12, 2025 at 11:43 AM#23
kate.chem said:
Keep the original post as written when you update it, and add the correction underneath.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

42 17GraceAZ_72, carl_compliance, DanielChem_CHI and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Dec 19, 2025 at 2:54 AM#24
kate.chem said:
Keep the original post as written when you update it, and add the correction underneath.

True, with the qualification that this is a self-selected group. The people for whom it did not work post less, and that shapes everything we think we know.

Last edited: Dec 19, 2025 at 7:54 AM
41 16tom_AK, josh_phd_bmore, roxy_nash and 38 others
Reply Quote Save Share Report
MarkLI_maint
Member
534
2,345
Jun 2024
Long Island, NY
Dec 25, 2025 at 6:08 PM#25
kate.chem said:
Keep the original post as written when you update it, and add the correction underneath.

This is exactly what I could not find anywhere else. Printing the relevant bit and taking it with me.

40 15bri_stats, pete_manc_UK, anna.melb_AU and 37 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register